Shockwave (SWAV) Receives Buyout Offer from J&J: What Investors Should Know

The 7investing Podcast - Podcast tekijän mukaan 7investing

kokeile Podimo ilmaiseksi 30! päivän ajan

kokeile Podimo ilmaiseksi 30! päivän ajan

universumia joka on täynnä satoja podcasteja ja äänikirjoja, klikkaa tätä kokeillaksesi

 Sponsored

Kategoriat:

Talous

ShockWave Medical (Nasdaq: SWAV), the innovative pioneer of intravascular lithotripsy, has received an all-cash acquisition offer from Johnson & Johnson (NYSE: JNJ) for $335 per share. In today's episode, 7investing advisors Luke Hallard and Simon Erickson discuss why we made ShockWave a 7investing recommendation, several financial details of the offer, and what investors should expect going forward.

Visit the podcast's native language site